Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

China Aims to Boost Elderly Vaccination Amid Reopening Pressure

Published 11/29/2022, 02:01 AM
Updated 11/29/2022, 02:45 AM
© Reuters China Aims to Boost Elderly Vaccination Amid Reopening Pressure

(Bloomberg) -- China said it would bolster vaccination among its senior citizens, a move regarded by health experts as crucial to reopening an economy stuck in an endless loop of harsh Covid Zero curbs amid the worst outbreak since the start of the pandemic.

Authorities plan to push shots harder in places like nursing centers, while making those unwilling to get inoculated provide a reason for their refusal, according to a statement Tuesday from the National Health Commission. The government will use big data to identify elderly people who need the vaccine, the statement said.

While more than 90% of China’s 1.4 billion people have been vaccinated with two shots -- a relatively high percentage globally -- the numbers decline with age, with the figure dropping for especially people over the age of 80. Only 65.7% of over 80-year-olds are fully vaccinated and just 40% have received booster shots. About 86% of those aged 60 and above have completed two shots.

The low elderly vaccination rate is viewed as a roadblock to opening up, like the rest of the world. Authorities fear mass infection among unprotected seniors could overwhelm the nation’s health-care infrastructure, yet haven’t done enough to persuade the vulnerable group to come forward for inoculation. While cash incentives and insurance for “vaccine accidents” have been offered by local officials to dispel hesitancy, the central government has forbidden the use of mandates, which have been effective in raising vaccine coverage in other countries.

China’s Covid Zero policy has increasingly come under pressure, with protests against the punishing regime erupting in cities from Beijing to Shanghai and Chengdu to the far western outpost of Kashgar. Frustrated citizens took to the streets last weekend, urging an end to the curbs. Besides bringing misery to tens of millions of people across the country, the restrictions have also disrupted businesses and slowed growth in the world’s second-largest economy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

©2022 Bloomberg L.P.

Latest comments

Cansino Bio (06185.hk) has an appoved vaxination for inhalation instead of injection by needle. Most hopefully this will encourage more older people in China to get vaxinated finally.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.